Curr cancer drug targets 影响因子
WebPubMed Central (PMC)链接:PubMed Central 平均审稿速度:网友分享经验:平均1月 平均录用比例:网友分享经验:约50% 在线出版周期: WebThis journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions.
Curr cancer drug targets 影响因子
Did you know?
WebBentham Science Publishers. Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest … Anti-Cancer Agents in Medicinal Chemistry ISSN (Print):1871-5206 ISSN … Articles By Disease - Welcome to Bentham Science Publisher Reprints are customized, reproductions of articles printed on high-quality paper for … Online Manuscript Submission and Tracking System: The Manuscript Processing … By Subject - Welcome to Bentham Science Publisher Recent Patents on Anti-Cancer Drug Discovery. ISSN: 2212-3970 (Online) … Anti-Cancer Agents in Medicinal Chemistry ISSN (Print):1871-5206 ISSN … Recent Patents on Anti-Cancer Drug Discovery . Impact Factor: 3.038 5-Year … Journal Catalog 2024. Catalog Description: Bentham Science Publishers’ 2024 … WebCurr Cancer Drug Targets. 2013 Jan;13(1):30-47. Authors ... Other drugs to consider are thalidomide, lenalidomide, antiangiogenic agents, tyrosine kinase inhibitors and heat shock protein 90 inhibitors, which all have both antileukemic and immunomodulatory effects. Relatively few clinical studies are available for patients with this high-risk ...
WebCurrent Cancer Drug Targets(当前的抗癌药物靶点)创刊于2001年,由BENTHAM SCIENCE PUBL LTD出版商出版,收稿方向涵盖医学 - 肿瘤学全领域,此期刊水平偏中 … Web介绍. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics …
Web期刊名称. CURR PROB CANCER/CURRENT PROBLEMS IN CANCER. ISSN. 0147-0272. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 6.769 (MedSci实时期刊指数) 5.25578 (5年期刊指数). WebAug 17, 2024 · 肿瘤学(ONCOLOGY)领域SCIE期刊及2024年影响因子排名part1. 哪些肿瘤学(ONCOLOGY)SCI期刊容易发表?. 影响因子是衡量期刊水平的重要指标,一般 …
Web介绍. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics …
WebApr 5, 2024 · Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery.. The journal … seastar electronic steeringWebCURRENT CANCER DRUG TARGETS. 出版年份:2001 年文章数:29 投稿命中率:43.75%. 出版周期:Monthly 自引率:1.2% 审稿周期:平均2.4月. 前往期刊查询. 期刊 … pubs gerrards crossWebMay 31, 2024 · Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer … pubs gemini warringtonWebCurr Cancer Drug Targets. 2024;19(9):688-697. doi: 10.2174/1568009619666190326123945. Authors ... testing prior to prescribing targeted therapy is crucial in identifying who can receive clinical benefit from specific cancer drugs. Over the last two decades, gastrointestinal stromal tumors (GISTs) have evolved from … pub sg geographical investigationWebCurr Cancer Drug Targets. 2024;21(7):558-574. doi: 10.2174/1568009621666210504091722. ... The microenvironment of gliomas includes non-cancer cells such as immune cells, fibroblasts, and cells of blood vessels, as well as secreted molecules and the extracellular matrix, and all these components play a vital … sea star feeding methodWebCurrent Research in Pharmacology and Drug Discovery (CRPHAR) is a new primary research, gold open access journal from Elsevier. CRPHAR publishes original papers, … seastar eps 4000WebCurrent Cancer Drug Targets. ISSN (Print): 1568-0096. ISSN (Online): 1873-5576. Volume 23 , Issues 11, 2024. This journal supports open access. seastar eps